Skip to content

A comparison of Hysterosalpingo-foam sonography (HyFoSy) and Hysterosalpingo-contrast sonography with saline medium (HyCoSy) in the assessment of tubal patency

A comparison of Hysterosalpingo-foam sonography (HyFoSy) and Hysterosalpingo-contrast sonography with saline medium (HyCoSy) in the assessment of tubal patency - A comparison of Hysterosalpingo-foam sonography (HyFoSy) and Hysterosalpingo-contrast sonography with saline medium (HyCoSy) in the assessment of tubal patency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016884
Enrollment
40
Registered
2015-03-23
Start date
2014-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive Medicine

Interventions

A routine non- contrast vaginal ultrasound assessment of the pelvic organs was performed before tubal evaluation. The procedure for HyCoSy using saline medium was as follows: The cervix was visualised

Sponsors

Neuvital Pte Ltd
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All patients referred for tubal patency assessment at the Singapore General Hospitals Centre for Assisted Reproduction were invited to participate. Inclusion criteria were subfertile women who required office tubal patency evaluation after assessment by a consultant gynaecologist.

Exclusion criteria

Exclusion criteria: Exclusion criteria were age below the legal limit for consent (21 years old), inability to give informed consent, active pelvic infection, active uterine bleeding (including menstruation) and refusal to undergo cross- over testing

Design outcomes

Primary

MeasureTime frame
The following outcome measures were used to assess diagnostic yield: -Proportion of patent tubes detected with the initial tubal patency test. -Proportion of possibly occluded or unexaminable tubes that were re- classified as patent on cross- over testing. Efficacy was defined as the proportion of patients who required cross- over testing (i.e had at least one possibly occluded or unexaminable tube on the initial tubal patency test).

Countries

Asia(except Japan)

Contacts

Public ContactLim Liqing Serene

Singapore General Hospital Obstetrics and Gynecology

pluiepluie@gmail.com81211630

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026